Recent posts

TypePostAuthorRepliesLast updated
PageKim Treanor, Communications and Development Claire Cassedy013 hours 59 min ago
Blog entry2017: miRecule/NIH license on MicroRNA Therapeutics for Treating Squamous Cell Carcinomas James Love03 days 19 hours ago
Blog entryUSTR Chief Innovation and Intellectual Property Negotiator James Love05 days 20 hours ago
PageDr. Diane Singhroy, Scientific and Technical Advisor Claire Cassedy01 week 12 hours ago
PageDaily Calendars of US Trade Representative Michael Froman 2013-2016 Claire Cassedy01 week 5 days ago
Blog entryDaily Calendar for Ambassador Ron Kirk, March 20 to May 1, 2009 KEI Staff01 week 5 days ago
Blog entryDaily Calendar for USTR head Ambassador Ron Kirk, for May to September 2009 James Love01 week 5 days ago
PageDaily Calendars of Deputy USTR Robert W. Holleyman II 2014-2016 Claire Cassedy01 week 5 days ago
PageDaily Calendars of Deputy USTR Micheal Punke 2013-2016 Claire Cassedy01 week 5 days ago
Blog entryKEI initial comments on NIH proposed grant of exclusive license on liver cancer treatment to Salubris Kim Treanor01 week 6 days ago
Page2017: Salubris Biotherapuetics: Bispecific, Biparatopic Antibody-Drug Conjugate for Human Liver Cancers James Love01 week 6 days ago
Blog entryKEI comments to USTR on the negotiating objectives for the modernization of NAFTA James Love02 weeks 3 days ago
PageXtandi Petition (filed in 2016, appealed in 2017) James Love02 weeks 4 days ago
Blog entryNIH response to KEI request for NIH policy on on the licensing of federally-funded CRISPR patented inventions. James Love02 weeks 4 days ago
Blog entryHouse Appropriations rejects Kaptur amendment (allow competition for gov funded drugs if prices higher than reference countries) Kim Treanor02 weeks 5 days ago
Page2017: NantBioScience - Commercial Application and Use of Fulvestrant in Combination Therapy for the Treatment of Cancers James Love02 weeks 5 days ago
Blog entry Senate Armed Services Committee directive on use of Bayh-Dole rights for DoD funded drugs Kim Treanor02 weeks 6 days ago
Blog entryKEI comments at July 25, 2017 civil society stakeholder forum at the 19th round of the RCEP negotiation James Love03 weeks 15 hours ago
Page2017: VeriLuce license of patents for pancreatic cancer treatment James Love03 weeks 15 hours ago
Page2017: GeneXion Oncology Prospective Grant of Exclusive Patent License for Mutant IDH1 Inhibitors Useful for Treating Cancer James Love03 weeks 18 hours ago
Page2017: PathoVax license on Chimeric L1/L2 Protein . .. Human Papillomavirus Vaccines James Love03 weeks 19 hours ago
PageZika: Resources on 2016-2017 Army Exclusive Patent License to Sanofi James Love03 weeks 6 days ago
Blog entryKEI and Médecins Sans Frontières propose contractual terms to protect access and affordability of Zika vaccine Kim Treanor03 weeks 6 days ago
Blog entry2017: Three documents leaked from RCEP negotiations, relating to investment, competition and services James Love04 weeks 3 days ago
Page RCEP: Regional Comprehensive Economic Partnership James Love04 weeks 3 days ago